← News
Macro· June 20, 2026 at 08:34 PM
ADMA Biologics (ADMA) Hit With Federal Securities Lawsuit Over Revenue Inflation Allegations - Yahoo Finance
Authored by·Editorially reviewed
Onur Erkan YıldızFounder, Financial Engineer · CMB-licensed
Higher education in Financial Engineering and Money & Capital Markets. SPK (Turkey CMB) licence. 16 years across institutional markets, research, and quant-driven analytics.
NeutralMedium impact
AI summary
ADMA Biologics (ADMA) Hit With Federal Securities Lawsuit Over Revenue Inflation Allegations Yahoo Finance
AI commentary is generated from public news feeds and is not investment advice.